Itonis Pharmaceuticals and Dr. Charles Hensley Hitting Production Milestones for Protection of Emesyl(TM) Nausea Remedy
November 18 2013 - 9:50AM
Marketwired
Itonis Pharmaceuticals and Dr. Charles Hensley Hitting Production
Milestones for Protection of Emesyl(TM) Nausea Remedy
LAGUNA HILLS, CA--(Marketwired - Nov 18, 2013) - Itonis, Inc.
(PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the
Zicam® cold remedy, are pleased to release their manufacturing
update for Emesyl™, the Company's over-the-counter homeopathic
product for the relief of nausea.
Since receiving the first order for the manufacturing of
Emesyl™, Oasis Health Products has hit some critical production and
scale-up milestones.
"The process has been a bit longer than expected but in the long
run, over-coming a substantial barrier to entry serves to protect
our proprietary formulations in the nausea relief product against
competitors' attempts at any improper replications," says Dr.
Charles Hensley. "An extremely important key to this product is not
only its efficacy but also having the product and its active blends
be difficult for competitors to duplicate. By working closely with
the manufacturer, we have been able to accomplish this by using a
dedicated Rotavap, which has allowed us to scale up our bench
formula while keeping the usually water insoluble actives in
solution in a way that does not create discomfort in the consumer's
the nasal passage."
About Itonis
Pharmaceuticals Itonis Pharmaceuticals, a new division of
Itonis, Inc., is headed by Charles Hensley, Ph.D. This division's
mission is to create and market over-the-counter and prescription
homeopathic products that better people's lives. Dr. Hensley is a
pioneer in the development and marketing of safe and effective
therapeutic nutraceutical and homeopathic preparations. He was a
founder of the company that launched the Zicam® Cold Remedy, making
the product a household name and forever changing the marketing and
product placement paradigm for homeopathic drugs in the United
States. Dr. Hensley and his team plan to use the same methodologies
to revolutionize the treatment of several other common ailments and
other chronic diseases.
About Itonis,
Inc. Itonis, Inc. (the "Company") was incorporated in the
state of Nevada on July 5, 2005 under the name of Kenshou, Inc.,
which later changed to Itonis, Inc. on December 2, 2005. For more
information, please visit www.itonisholdings.com.
Safe Harbor:
Statements in this press release may constitute forward-looking
statements and are subject to numerous risks and uncertainties,
including the failure to complete successfully the development of
new or enhanced products, the Company's future capital needs, the
lack of market demand for any new or enhanced products the Company
may develop, any actions by the Company's affiliates that may be
adverse to the Company, the success of competitive products, other
economic factors affecting the Company and its markets, seasonal
changes, and other risks detailed from time to time in the
Company's filings with the U.S. Securities and Exchange Commission.
The actual results may differ materially from those contained in
this press release. The Company disclaims any obligation to update
any statements in this press release.
Contact: Itonis, Inc. Email Contact
Itonis (PK) (USOTC:ITNS)
Historical Stock Chart
From Jan 2025 to Feb 2025
Itonis (PK) (USOTC:ITNS)
Historical Stock Chart
From Feb 2024 to Feb 2025